小児慢性副鼻腔炎治療の世界市場:規模・現状・予測2019-2025

【英語タイトル】Global Pediatric Chronic Rhinosinusitis Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR20FB12402)・商品コード:QYR20FB12402
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:99
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、小児慢性副鼻腔炎治療の世界市場について調査・分析し、小児慢性副鼻腔炎治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(ステロイド、抗生物質、抗真菌療法、その他)、用途別(病院薬局、小売薬局、オンライン薬局)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の小児慢性副鼻腔炎治療市場動向
・主要企業別マーケットシェア
・小児慢性副鼻腔炎治療の種類別市場規模2014-2019
(ステロイド、抗生物質、抗真菌療法、その他)
・小児慢性副鼻腔炎治療の用途別市場規模2014-2019
(病院薬局、小売薬局、オンライン薬局)
・小児慢性副鼻腔炎治療の北米市場:主要企業・種類別/用途別市場規模
・小児慢性副鼻腔炎治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・小児慢性副鼻腔炎治療の中国市場:主要企業・種類別/用途別市場規模
・小児慢性副鼻腔炎治療の日本国内市場:主要企業・種類別/用途別市場規模
・小児慢性副鼻腔炎治療の東南アジア市場:主要企業・種類別/用途別市場規模
・小児慢性副鼻腔炎治療のインド市場:主要企業・種類別/用途別市場規模
・小児慢性副鼻腔炎治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Pfizer、Bayer、Novartis、Sanofi、AstraZeneca、Teva Pharmaceutical、Sumitomo Dainippon Pharma、Cipla、Lyra Therapeutics)
・小児慢性副鼻腔炎治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Pediatric chronic Rhinosinusitis is one of the major and common disorder among infants with significant morbidity. Its diagnosis involves sinus symptoms, with prolonged duration requiring standard medical therapy for more than 90 days. The main causative factors for pediatric chronic rhinosinusitis include viral attack, allergic reactions, and physical changes in children leading to chronic obstruction.In 2018, the global Pediatric Chronic Rhinosinusitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pediatric Chronic Rhinosinusitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pediatric Chronic Rhinosinusitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Pfizer
Bayer
Novartis
Sanofi
AstraZeneca
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Cipla
Lyra Therapeutics

Market segment by Type, the product can be split into
Steroids
Antibiotics
Antifungal Therapy
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pediatric Chronic Rhinosinusitis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Pediatric Chronic Rhinosinusitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pediatric Chronic Rhinosinusitis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Steroids
1.4.3 Antibiotics
1.4.4 Antifungal Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pediatric Chronic Rhinosinusitis Treatment Market Size
2.2 Pediatric Chronic Rhinosinusitis Treatment Growth Trends by Regions
2.2.1 Pediatric Chronic Rhinosinusitis Treatment Market Size by Regions (2019-2025)
2.2.2 Pediatric Chronic Rhinosinusitis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Pediatric Chronic Rhinosinusitis Treatment Market Size by by Players
3.1.1 Global Pediatric Chronic Rhinosinusitis Treatment Revenue by by Players (2014-2019)
3.1.2 Global Pediatric Chronic Rhinosinusitis Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Pediatric Chronic Rhinosinusitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Pediatric Chronic Rhinosinusitis Treatment Key Players Head office and Area Served
3.3 Key Players Pediatric Chronic Rhinosinusitis Treatment Product/Solution/Service
3.4 Date of Enter into Pediatric Chronic Rhinosinusitis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2014-2019)
4.2 Global Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
5.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in North America
5.3 North America Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
5.4 North America Pediatric Chronic Rhinosinusitis Treatment Market Size by Application

6 Europe
6.1 Europe Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
6.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Europe
6.3 Europe Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
6.4 Europe Pediatric Chronic Rhinosinusitis Treatment Market Size by Application

7 China
7.1 China Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
7.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in China
7.3 China Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
7.4 China Pediatric Chronic Rhinosinusitis Treatment Market Size by Application

8 Japan
8.1 Japan Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
8.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Japan
8.3 Japan Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
8.4 Japan Pediatric Chronic Rhinosinusitis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
9.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
9.4 Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size by Application

10 India
10.1 India Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
10.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in India
10.3 India Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
10.4 India Pediatric Chronic Rhinosinusitis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
11.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Central & South America
11.3 Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
11.4 Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.1.4 Pfizer Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019))
12.1.5 Pfizer Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.2.4 Bayer Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.3.4 Novartis Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.4.4 Sanofi Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.5.4 AstraZeneca Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.6.4 Teva Pharmaceutical Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.6.5 Teva Pharmaceutical Recent Development
12.7 Sumitomo Dainippon Pharma
12.7.1 Sumitomo Dainippon Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.7.4 Sumitomo Dainippon Pharma Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.7.5 Sumitomo Dainippon Pharma Recent Development
12.8 Cipla
12.8.1 Cipla Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.8.4 Cipla Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.8.5 Cipla Recent Development
12.9 Lyra Therapeutics
12.9.1 Lyra Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.9.4 Lyra Therapeutics Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.9.5 Lyra Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details



【掲載企業】

Pfizer、Bayer、Novartis、Sanofi、AstraZeneca、Teva Pharmaceutical、Sumitomo Dainippon Pharma、Cipla、Lyra Therapeutics

★調査レポート[小児慢性副鼻腔炎治療の世界市場:規模・現状・予測2019-2025] (コード:QYR20FB12402)販売に関する免責事項を必ずご確認ください。
★調査レポート[小児慢性副鼻腔炎治療の世界市場:規模・現状・予測2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆